239 related articles for article (PubMed ID: 21211107)
1. Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels.
Klugmann M; Klippenstein V; Leweke FM; Spanagel R; Schneider M
Int J Neuropsychopharmacol; 2011 May; 14(4):505-17. PubMed ID: 21211107
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-D-aspartate receptors.
Alén F; Santos A; Moreno-Sanz G; González-Cuevas G; Giné E; Franco-Ruiz L; Navarro M; López-Moreno JA
Neuroscience; 2009 Jan; 158(2):465-73. PubMed ID: 18977415
[TBL] [Abstract][Full Text] [Related]
3. Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment.
Wegener N; Koch M
Brain Res; 2009 Feb; 1253():81-91. PubMed ID: 19094973
[TBL] [Abstract][Full Text] [Related]
4. Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2.
Schneider M; Drews E; Koch M
Behav Pharmacol; 2005 Sep; 16(5-6):447-54. PubMed ID: 16148450
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
6. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring.
Antonelli T; Tomasini MC; Tattoli M; Cassano T; Tanganelli S; Finetti S; Mazzoni E; Trabace L; Steardo L; Cuomo V; Ferraro L
Cereb Cortex; 2005 Dec; 15(12):2013-20. PubMed ID: 15788701
[TBL] [Abstract][Full Text] [Related]
7. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
Gomes FV; Guimarães FS; Grace AA
Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
[TBL] [Abstract][Full Text] [Related]
8. Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapine.
Leweke FM; Schneider M
Int J Neuropsychopharmacol; 2011 Feb; 14(1):43-51. PubMed ID: 20678304
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats.
Schneider M; Schömig E; Leweke FM
Addict Biol; 2008 Sep; 13(3-4):345-57. PubMed ID: 18782382
[TBL] [Abstract][Full Text] [Related]
10. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol.
Pava MJ; Blake EM; Green ST; Mizroch BJ; Mulholland PJ; Woodward JJ
Psychopharmacology (Berl); 2012 Jan; 219(1):137-47. PubMed ID: 21701813
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
[TBL] [Abstract][Full Text] [Related]
13. Effects of SR141716 and WIN 55,212-2 on tolerance to ethanol in rats using the acute and rapid procedures.
Lemos JI; Takahashi RN; Morato GS
Psychopharmacology (Berl); 2007 Oct; 194(2):139-49. PubMed ID: 17546513
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
15. Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP).
Marszalek-Grabska M; Smaga I; Surowka P; Grochecki P; Slowik T; Filip M; Kotlinska JH
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360704
[TBL] [Abstract][Full Text] [Related]
16. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
[TBL] [Abstract][Full Text] [Related]
17. Effects of prenatal exposure to the CB-1 receptor agonist WIN 55212-2 or CO on the GABAergic neuronal systems of rat cerebellar cortex.
Benagiano V; Lorusso L; Flace P; Girolamo F; Rizzi A; Sabatini R; Auteri P; Bosco L; Cagiano R; Ambrosi G
Neuroscience; 2007 Nov; 149(3):592-601. PubMed ID: 17916407
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation.
López-Moreno JA; González-Cuevas G; Rodríguez de Fonseca F; Navarro M
J Neurosci; 2004 Sep; 24(38):8245-52. PubMed ID: 15385608
[TBL] [Abstract][Full Text] [Related]
19. CB
Kirson D; Oleata CS; Parsons LH; Ciccocioppo R; Roberto M
Addict Biol; 2018 Mar; 23(2):676-688. PubMed ID: 28656627
[TBL] [Abstract][Full Text] [Related]
20. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
Radziszewska E; Bojanowska E
Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]